PP-60
PP-60 is an apoptosis inducer. PP-60 inhibits the proliferation of cancer cells and induces cancer cell apoptosis. PP-60 exerts anti-tumor effects in nude mouse liver tumor models. PP-60 is applicable to research related to cancers such as liver cancer, lung cancer, and prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C142H252N36O40
- Masse moléculaire:3103.74
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
PP-60 (24 h) exhibits potent antiproliferative activity against HepG2, A549 and PC-3 cells, with IC50 values of 1.73, 2.15 and 2.69 μM[1].
PP-60 (2 μM; 2-4 h) exhibits excellent cellular uptake capacity[1].
PP-60 (0-5 μM) inhibits G2 phase cell cycle progression in HepG2 cells in a dose-dependent manner, and the percentage of cells in the G2 phase reaches approximately 35% at a concentration of 5 μM[1].
PP-60 (0-5 μM, 6 h) induces apoptosis in HepG2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2 cells
-
Concentration:2 μM
-
Incubation Time:2, 4 h
-
Result:Increased FITC fluorescence signal intensity indicates a stronger cellular uptake capacity.
-
Cell Line:HepG2 cells
-
Concentration:0, 1, 2, 5 μM
-
Incubation Time:6 h
-
Result:Induced apoptosis, at a concentration of 5 μM, the apoptosis rate is approximately 80%.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice (female; HepG2 (2 × 106 cells/mouse) xenograft model)[1]
-
Dosage:0.5 mg per mouse
-
Administration:intratumoral injection; on day 1, 6, and 15
-
Result:Exhibited potent antitumor activity.
Reduced tumor volume; decreased tumor weight; showed the highest caspase 3 positive staining; reduced Ki67 positive cells to the lowest level; induced significant tumor cell apoptosis.
Chemical Information
-
Masse moléculaire 3103.74
-
Formule C142H252N36O40
-
Sequence
Ac-{Arg(β-Glu(1→4)-α-Glu)}-Leu-{(S)-2-(4-pentenyl)alanine}-Lys-Asp-Lys-{(S)-2-(4-pentenyl)alanine}-Lys-Gly-Ile-Gly-Lys-Leu-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-{(S)-2-(4-pentenyl)alanine}--Lys-Thr-Leu-{(S)-2-(4-pentenyl)alanine}-NH2 (RCM bridge: {S5}3-{S5}7, {S5}22-{S5}26)
-
Sequence Shortening
Ac-{Arg(β-Glu(1→4)-α-Glu)}-L-{S5}-KDK-{S5}-KGIGKLAGKAALGA-{S5}-KTL-{S5}-NH2 (RCM bridge: {S5}3-{S5}7, {S5}22-{S5}26)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)